Sameer Dewan - 10 Jan 2026 Form 4 Insider Report for Genpact LTD (G)

Reporting relationship: Senior Vice President
Issuer ticker: G
Reported as of: 10 Jan 2026
Net transaction value: -$1,175,642
SEC form: 4
Accepted by SEC: 13 Jan 2026, 21:35:07 UTC
Prior SEC filing: 13 Nov 2025
Next SEC filing: 03 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan

Key filing fact

Sameer Dewan filed Form 4 for Genpact LTD (G) on 13 Jan 2026.

Key facts

This page summarizes Sameer Dewan's Form 4 filing for Genpact LTD (G).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Jan 2026, 21:35.

Change

Previous filing in this sequence was filed on 13 Nov 2025.
Current net transaction value: -$1,175,642.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002015050 Primary reporting owner

Dewan Sameer

Relationship: Senior Vice President
Address: C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Thomas D. Scholtes, as Attorney-in-fact for Sameer Dewan
Signature date: 13 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

G transaction

Common Shares

Tax liability

Transaction value: $471,787
Shares: -9,780
Change %: -16%
Price: $48.24
Shares after: 52,837
Date: 10 Jan 2026
Ownership: Direct
Footnotes: F1

G transaction

Common Shares

Sale

Transaction value: $703,855
Shares: -15,088
Change %: -29%
Price: $46.65
Shares after: 37,749
Date: 13 Jan 2026
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Represents shares withheld for payment of taxes upon the vesting of restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3.

Footnote F2

The sales transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.

Footnote F3

The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.40 to $47.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.